Literature DB >> 1419600

Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen.

A J Stewart1, B R Westley, F E May.   

Abstract

A number of growth factors have been implicated in the control of the proliferation of breast cancer cells and some have been reported to mediate the proliferative effects of oestradiol. MCF-7 cells were treated with growth factors in the presence and absence of oestradiol. Oestradiol increased the response of cells to the proliferative effects of epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha) and basic fibroblast growth factor (bFGF). Platelet derived growth factor (PDGF) and cathepsin D had no effect in the presence or absence of oestradiol while TGF-beta slightly reduced the stimulation by oestradiol. In the absence of oestradiol, there was little effect of combinations of growth factors although the effects of bFGF and IGF-I were additive. In the presence of oestradiol, the effects of bFGF and TGF-alpha were additive whereas bFGF acted as an IGF-I antagonist. Overall, bFGF had the greatest effect on cell proliferation although this was less marked than the previously described effect of the IGFs and insulin. The effects of oestradiol on the sensitivity of cells to the proliferative effects of bFGF did not appear to result from regulation of bFGF receptor expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419600      PMCID: PMC1977408          DOI: 10.1038/bjc.1992.330

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.

Authors:  D A Bronzert; P Pantazis; H N Antoniades; A Kasid; N Davidson; R B Dickson; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.

Authors:  B S Leung; A H Potter
Journal:  J Cell Biochem       Date:  1987-07       Impact factor: 4.429

3.  Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.

Authors:  F Minuto; P Del Monte; A Barreca; A Alama; G Cariola; G Giordano
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

4.  The value of estrogen and progesterone receptors in the treatment of breast cancer.

Authors:  C K Osborne; M G Yochmowitz; W A Knight; W L McGuire
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

5.  Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

Authors:  C L Arteaga; A K Tandon; D D Von Hoff; C K Osborne
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

6.  Different growth factors stimulate cell division of rat mammary epithelial, myoepithelial, and stromal cell lines in culture.

Authors:  J A Smith; D P Winslow; P S Rudland
Journal:  J Cell Physiol       Date:  1984-06       Impact factor: 6.384

Review 7.  Regulation of human breast cancer by secreted growth factors.

Authors:  K J Cullen; D Yee; S E Bates; N Brunner; R Clarke; R E Dickson; K K Huff; S Paik; N Rosen; E Valverius
Journal:  Acta Oncol       Date:  1989       Impact factor: 4.089

8.  High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell.

Authors:  M Kan; D DiSorbo; J Z Hou; H Hoshi; P E Mansson; W L McKeehan
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

9.  Mitogenic activity of pituitary hormones on cell cultures of normal and carcinogen-induced tumor epithelium from rat mammary glands.

Authors:  P S Rudland; R C Hallowes; H Durbin; D Lewis
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

10.  Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells.

Authors:  M D Johnson; B R Westley; F E May
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more
  19 in total

1.  1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.

Authors:  Sunil K Halder; J Shawn Goodwin; Ayman Al-Hendy
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

2.  Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.

Authors:  Wen-Fang Chen; Wai-Sum Lau; Pik-Yuen Cheung; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures.

Authors:  A de Cupis; P Pirani; L Fazzuoli; R E Favoni
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Nov-Dec       Impact factor: 2.416

Review 4.  Antiestrogen action and growth factor regulation.

Authors:  L C Murphy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 5.  Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

Authors:  D Yee; A V Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

6.  ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy.

Authors:  Luiza Kanczuga-Koda; Mariusz Koda; Jakub Tomaszewski; Katarzyna Jarzabek; Joanna Lotowska; Marek Baltaziak; Urszula Sulkowska; Maria Sobaniec-Lotowska; Stanisław Sulkowski
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

7.  Plasma TGF-beta1-related survival of postmenopausal metastatic breast cancer patients.

Authors:  D Nikolić-Vukosavljević; N Todorović-Raković; M Demajo; V Ivanović; B Nesković; M Markićević; Z Nesković-Konstantinović
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  [Role of estrogen, estrogen receptors, and aromatase in the pathogenesis of uterine adenomyosis].

Authors:  Yu-Yan Zeng; Yong-Ge Guan; Kun-Yin Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

Review 9.  The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.

Authors:  Morteza Motallebnezhad; Leili Aghebati-Maleki; Farhad Jadidi-Niaragh; Hamid Nickho; Hosein Samadi-Kafil; Karim Shamsasenjan; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2016-07-21

10.  Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.

Authors:  A de Cupis; D Noonan; P Pirani; A Ferrera; L Clerico; R E Favoni
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.